QVEQLI Trademark

Trademark Overview


On Thursday, June 18, 2020, a trademark application was filed for QVEQLI with the United States Patent and Trademark Office. The USPTO has given the QVEQLI trademark a serial number of 90008197. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2024. This trademark is owned by Ascendis Pharma Endocrinology Division A/S. The QVEQLI trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Medical Instrument Products categories with the following description:

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and pe...

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases

Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispenser...
qveqli

General Information


Serial Number90008197
Word MarkQVEQLI
Filing DateThursday, June 18, 2020
Status700 - REGISTERED
Status DateTuesday, November 26, 2024
Registration Number7575036
Registration DateTuesday, November 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements


Goods and ServicesDownloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
Goods and ServicesPharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases
Goods and ServicesMedical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, July 16, 2020
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 16, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAscendis Pharma Endocrinology Division A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Party NameAscendis Pharma Endocrinology Division A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Party NameAscendis Pharma Endocrinology Division A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Trademark Events


Event DateEvent Description
Monday, June 22, 2020NEW APPLICATION ENTERED
Thursday, July 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 22, 2020ASSIGNED TO EXAMINER
Tuesday, September 22, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 22, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 22, 2021SUSPENSION LETTER WRITTEN
Thursday, April 22, 2021LETTER OF SUSPENSION E-MAILED
Thursday, April 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 26, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 9, 2021ASSIGNED TO LIE
Tuesday, July 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 13, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, August 17, 2021ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, May 12, 2022SOU EXTENSION 1 FILED
Thursday, May 12, 2022SOU EXTENSION 1 GRANTED
Saturday, May 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 16, 2022SOU EXTENSION 2 FILED
Wednesday, November 16, 2022SOU EXTENSION 2 GRANTED
Friday, November 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Friday, May 12, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 12, 2023SOU EXTENSION 3 FILED
Friday, May 12, 2023SOU EXTENSION 3 GRANTED
Tuesday, May 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023ASSIGNED TO EXAMINER
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 4 FILED
Thursday, November 16, 2023SOU EXTENSION 4 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024NOTICE OF ALLOWANCE CANCELLED
Thursday, May 16, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 4, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED